Europe has taken the lead in the development and commercialization of biosimilar medicines because they have the same effectiveness as biological medicines and can be used in treatment of serious diseases such as cancer, at a much lower cost. In 2006, the development of biosimilar medicines began, a technology that caused a revolution in the […]
Although its personalized medicine`s products aren’t in the market yet, the test for early colon cancer detection, ‘ColoFast’, might be available the next year in the European Union and the United States of America. How do Amadix’s advances benefit cancer patients? Find out below. Amadix is a Spanish biotech company founded in 2010 that develops […]
Medmesafe is a digital platform dedicated to the analysis and genetic counseling. In fact, this is the first online platform of predictive and personalized medicine to offer this type of service, with which you can meet your genetic predisposition to develop different types of diseases. That a person knows the state of their genes allows her to […]
On the International Day of Action against Migraine we present the latest advances arising within the therapy field of this neurological condition so widespread and with severe disabling effects. A medical revolution is brewing around this pathology, emerging the foundations of a medicine through food, and not focused only on the use of drugs. Medical nutrition represents […]
PharmaMar, world-leading biopharmaceutical company in the discovery and development of innovative marine-derived anticancer drugs, announced yesterday the signing of a commercialization and distribution license agreement with Pint Pharma International, S.A., company with headquartes in Viene, Austria, and expert in the latinoamerican rare diseases market. The signing allows Pint Pharma to commercialize the marine-derived anticancer drug Aplidin® […]
The Belgian company OncoDNA with headquarters in Spain, specialized in medicine of precision and in cancer diagnosis and treatment, has just signed a collaboration agreement with the Spanish center of reference at MD Anderson Cancer Center Madrid, which is a subsidiary of MD Anderson Cancer Center in Houston, Texas (USA), one of the most prestigious centers for diagnosis, treatment, and cancer research […]
BN201 is the first SGK2 selective agonist in its class that promotes remyelination and neuroprotection, by offering a solution that changes the playing field in the treatment of neurodegenerative diseases, giving us certain advantages to begin to combat them. Has recently been initiated its phase 1 clinical trial in the United Kingdom, and in order to speed up and tie well each place in […]
During our lifetime it’s inevitable for us to make use of healthcare centres, like hospitals or other healthcare facilities. Although progress has been made in hospital care and public health, there’s still a serious problem that risks patient’s lives: nosocomial infections. Nosocomial infections, also known as hospital-acquired infections, are contracted by patients in a hospital […]
If you don’t know multiresistant bacteria (MRB), you should. These bacteria are responsible of the death of 700.000 people over a year, and it has been estimated it will be 10 million by the end of 2050 year If we don’t find a treatment to stop them. MRD appeared because they have developed resistance against […]
Information technologies and informatics are becoming each day more essential to our life, infiltrating into every knowledge area. These subjects have merged with biomedicine leading to bioinformatics and bioengineering, which allows us to address biological matters from another point of view and develop new equipment to improve research, diagnosis and treatment. Since 2014 eVIA […]